Added by | standudu |
---|---|
Group name | EquipeCTCS |
Item Type | Attachment |
Title | PubMed entry |
URL | http://www.ncbi.nlm.nih.gov/pubmed/35302657 |
Accessed | 2022/07/29 - 13:49:36 |
Date Added | 2022/07/29 - 11:49:36 |
Date Modified | 2022/07/29 - 11:49:36 |
Parent item | In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2 |